Find Funding Opportunities

The purpose of this notice is to inform applicants of the early termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". The September 7, 2023 AIDS date has been cancelled.

Extending these NOFOs by one receipt date.

The purpose of this notice is to inform applicants of NINDS' participation in PAR-23-109 "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)".

TheOffice of Research Quality at the National Institute of Neurological Disorders and Stroke (NINDS) is issuing this notice to inform the extramural research community about principles of rigorous biomedical research that have not yet been selected for development into educational units by previous awardees of theMaterials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) funding opportunity. ?One receipt date remains for METER: October 10, 2023.

Adding a receipt date.

The purpose of this trans-NIH Notice of Special Interest (NOSI) is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering and participating Institutes and Centers (ICs) invite SBIR/STTR applications to develop technologies or tools to quantitatively predict or indicate an increased risk for maternal morbidity and mortality (MMM). This NOSI is part of the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) initiative, which supports research to reduce preventable causes of maternal deaths and improve health for women before, during, and after delivery.

The purpose of this notice is to extend PAR-20-185 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)" by one additional council round.

TBD

TBD

The National Institutes of Health (NIH) announces the continuation of the U.S. entity of the U.S.-Japan Brain Research Cooperative Program (BRCP). This administrative supplement program will provide funds to currently active research grants that are currently supported by one of the participating NIH Institutes and Centers. This Notice is soliciting administrative supplements for the following mechanisms ONLY: DP1, DP2, DP1, DP2, DP5, R01, R03, R21, R33 , R34, R37, R61, U01, UH2, and UH3.The purpose of the BRCP is to promote scientist exchange, training, and collaborations in basic, translational and clinical research between neuroscientists from the U.S. and Japan.The U.S. entity of the BRCP supports the following activities:1) Visit of U.S. scientists to conduct collaborative research and/or to acquire advanced research skills in Japanese institutions,2) Joint workshops to exchange scientific information and to foster collaborations.